Tejas Pradhan

So, for full year FY26 , could you give a sense on what the growth would be , excluding your largest product in agro CSM business?

Okay. So, just apart from the new molecules, even the existing molecules which you would have launched prior to that, right? So, if we just strip out the impact of the largest product, p yroxasulfone, excluding that, would there have been growth in FY26 in CSM exports or that would have been a YoY decline?

Okay. Understood. And secondly, on the contract assets, now we have seen a reduction from INR 1,000 crore as of December ‘2 5 to INR 700 crore as of March ‘26 . Now, while that has reduced, even on a YoY basis, it is still higher. I think in March ‘2 5, it was around INR 400 crore, right?

Sir, most of my questions were answered, just to wanted a data point on the lead distance this quarter?